STOCK TITAN
  1. Home
  2. News
  3. LH

Laboratory Corp. Of America Holdings - LH STOCK NEWS

Welcome to our dedicated news page for Laboratory Of America Holdings (Ticker: LH), a resource for investors and traders seeking the latest updates and insights on Laboratory Of America Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Laboratory Of America Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Laboratory Of America Holdings's position in the market.

News
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Labcorp (NYSE: LH) to participate in fireside chat at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
conferences
-
News
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
Rhea-AI Summary
Madryn Asset Management, LP (Madryn) urges shareholders to vote 'AGAINST' the proposed merger between SomaLogic, Inc. (SLGC) and Standard BioTools Inc. (LAB). Four significant shareholders, including the company founder, have openly stated their opposition to the merger, highlighting concerns about undervaluation and a flawed process. The recommendation from proxy advisory service ISS only offered 'cautionary support' for the merger, leaving room for shareholders to vote 'AGAINST' the transaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) responds to Madryn Asset Management's misleading press release regarding the pending merger with Standard BioTools (Nasdaq: LAB).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
none
News
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
Rhea-AI Summary
Madryn Asset Management, LP (Madryn) disclosed that SomaLogic, Inc. (SLGC) failed to engage with Labcorp, a leading strategic partner, before pursuing a merger with Standard BioTools. Madryn calls for a delay of the shareholder meeting due to concerns about maximizing value in the sale process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
none
-
News
Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship
Rhea-AI Summary
Labcorp (NYSE: LH) expands its diagnostic capabilities and services through the completion of a transaction with Legacy Health, acquiring select assets of Legacy's outreach laboratory business and managing Legacy's inpatient hospital laboratories. This move aims to benefit communities in Oregon and Southwest Washington by providing more direct and convenient access to Labcorp's industry-leading laboratory services and diagnostic testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
none
-
News
Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
Rhea-AI Summary
Labcorp (NYSE: LH) Announces Collaboration with Geneoscopy Inc. to Expand Access to Colorectal Cancer Screening Test - Geneoscopy Inc. and Labcorp have formed a strategic collaboration to increase patient and provider access to a next-generation colorectal cancer screening test. The test, currently under FDA review, offers at-home collection and high sensitivity for early cancer detection. The collaboration aims to reduce barriers to screening and address health inequities by making the test conveniently available through Labcorp's comprehensive screening programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
none
News
Ovia Health Unveils New Fertility and Family Building Benefit
Rhea-AI Summary
Ovia Health by Labcorp (Ovia) announces a first-of-its-kind Fertility and Family Building Benefit, offering comprehensive support for pre-conception, adoption, and surrogacy. The customizable solution aims to remove barriers to care access and provide inclusive support for diverse family-building journeys. The benefit includes the Ovia Wallet™, care navigation, and concierge support, addressing the needs of employers and health plans to improve health outcomes and lower costs, while also promoting greater health equity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
none
-
News
Labcorp Announces 2023 Third Quarter Results
Rhea-AI Summary
Labcorp updates full-year guidance after reporting 6.6% revenue growth in Q3. Advanced hospital and health systems strategy through new agreements. Launches new test for Alzheimer's disease diagnosis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.16%
Tags
earnings
-
News
Labcorp Declares Quarterly Dividend
Rhea-AI Summary
Labcorp declares cash dividend of $0.72 per share of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
dividends
News
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Rhea-AI Summary
Labcorp launches blood-based test for Alzheimer's disease detection
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
none
Stock LH logo
Laboratory Corp. Of America Holdings

NYSE:LH

LH Rankings

#571 Ranked by Market Cap
#1736 Ranked by Stock Gains
#1642 Ranked by Dividends

LH Stock Data

17.31B
83.67M
0.34%
98.27%
2.29%
Diagnostic Imaging Centers
Health Care and Social Assistance
Link
US
Burlington

About LH

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.